RJB-01

N/A

Report date: 2023/10/10 16:22:14

Base Information

Drug NameRJB-01
Drug Alias NameRJB-01
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionFibroblast growth factor 21 agonistsTransforming growth factor beta 1 activators
TargetsFibroblast growth factor 21Transforming growth factor beta 1
Therapy Area/IndicationsMetabolic DiseasesHeart DiseasesKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRejuvenate Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRejuvenate Bio Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesHeart DiseasesKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A